Champions Oncology Inc Revenue per Employee (CSBR), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Champions Oncology Inc   (NASDAQ: CSBR)
 

Champions Oncology Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 8.84% in the first quarter 2026, year on year to cumulative value of $61 million, Champions Oncology Inc 's revenue per employee grew on a trailing twelve months basis to $ 283,467, this marks a new company high.
Within the Healthcare sector Employees of 379 other companies have achieved higher revenue per employee. While Champions Oncology Inc 's total ranking has deteriorated compared to the previous quarter from 2958 to 3080. Champions Oncology Inc has 214 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CSBR Revenue per Employee (Jul 31 2026)
I. Quarter		 (Apr 30 2026)
IV. Quarter		 (Jan 31 2026)
III. Quarter		 (Oct 31 2025)
II. Quarter		 (Jul 31 2025)
I. Quarter
Y / Y Revenue Change 8.84 % 11.99 % -2.82 % 11.46 % -0.47 %
Sales per Employee (TTM) $ 283,467 277,687 270,766 273,009 265,785
CSBR's Total Ranking # 3080 # 2958 # 2229 # 2424 # 1972
Seq. Revenue Change 10.09 % -16.44 % 10.14 % 7.43 % 13.27 %

CSBR Company Profile >> Back to CSBR Efficiency Comparisons >> Compare CSBR Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 51
Healthcare Sector # 380
Overall Market # 3080

Revenue per Employee Statistics
High Average Low
$ 283,467 $ 150,576 $ 37,757
(Jul 31 2026)   (Jan 31 2015)



Financial Statements
Champions Oncology Inc 's Revenue MRQ $ 15 Millions Visit CSBR's Income Statement
Champions Oncology Inc 's Revenues TTM $ 61 Millions Visit CSBR's aggregate revenue growth
What are CSBR's Sales? Visit CSBR's Sales by Segment




Other Ratios
Champions Oncology Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CSBR's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CSBR's Competitors
Revenue per Employee for CSBR's Suppliers
Revenue per Employee for CSBR's Customers

You may also want to know
CSBR's Sales Growth Rates CSBR's Pe Price to earnings ratio CSBR's Receivables Turnover Ratio CSBR's Stock Quote
CSBR's Net Income Growth Rates CSBR's Ps Price to Sales ratio CSBR's Sales per Employee CSBR's Asset Turnover Ratio
CSBR's Net Margin CSBR's Pb Price to Book ratio CSBR's Financial Strength Ratios CSBR's Dividend Payout Ratio
Date modified: 2026-09-13T23:25:19+00:00




Companies with similar Revenue per Employee for 12 months ending Jul 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jul 31 2026Number of Employees Jul 31 2026
Accuray Incorporated  495,467.24 $ 400.833  Million 809 
Resmed Inc   495,001.76 $ 5,628.170  Million 11,370 
Adaptive Biotechnologies Corporation  493,719.55 $ 308.081  Million 624 
Carlsmed Inc   491,787.40 $ 62.457  Million 127 
Viatris Inc   491,243.33 $ 14,737.300  Million 30,000 
Invivyd Inc   478,401.64 $ 58.365  Million 122 
Maravai Lifesciences Holdings Inc   477,898.85 $ 207.886  Million 435 
Moderna Inc   474,042.55 $ 2,228.000  Million 4,700 
Guardant Health Inc   472,108.94 $ 1,183.105  Million 2,506 
Neuropace Inc   471,866.03 $ 98.620  Million 209 
Skinhealth Systems Inc   471,817.29 $ 289.224  Million 613 
Pelthos Therapeutics Inc   470,695.65 $ 43.304  Million 92 
Inogen Inc   470,523.24 $ 354.304  Million 753 
Regenxbio Inc   470,301.89 $ 174.482  Million 371 
4d Molecular Therapeutics Inc   469,428.57 $ 92.008  Million 196 
Stryker Corp  461,375.00 $ 25,837.000  Million 56,000 
Atara Biotherapeutics Inc   460,857.14 $ 6.452  Million 14 
Glaukos Corp  457,066.73 $ 500.031  Million 1,094 
Treace Medical Concepts Inc   456,237.78 $ 205.307  Million 450 
Medpace Holdings Inc   448,756.13 $ 2,782.288  Million 6,200 
Sight Sciences Inc   448,123.66 $ 83.351  Million 186 
Dexcom Inc   447,639.64 $ 4,968.800  Million 11,100 
Haemonetics Corporation  447,145.88 $ 1,351.722  Million 3,023 
Nakamoto Inc   445,571.28 $ 28.962  Million 65 
Livanova Plc  445,488.48 $ 1,470.112  Million 3,300 
Rockwell Medical inc   444,757.96 $ 69.827  Million 157 
Teladoc Health Inc   444,550.00 $ 2,489.480  Million 5,600 
Trisalus Life Sciences Inc   442,931.37 $ 45.179  Million 102 
Kymera Therapeutics Inc   441,176.47 $ 105.000  Million 238 
Twist Bioscience Corporation  441,060.27 $ 431.798  Million 979 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.